Felodipine

Catalog No.S1885

Felodipine is a selective L-type Ca2+ channel blocker with IC50 of 0.15 nM.

Price Stock Quantity  
In DMSO USD 130 In stock
USD 97 In stock
USD 310 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Felodipine  Chemical Structure

Felodipine Chemical Structure
Molecular Weight: 384.25

Validation & Quality Control

Quality Control & MSDS

Related Compound Libraries

Felodipine is available in the following compound libraries:

Product Information

  • Compare Calcium Channel Chemicals
    Compare Calcium Channel Products
  • Research Area

Product Description

Biological Activity

Description Felodipine is a selective L-type Ca2+ channel blocker with IC50 of 0.15 nM.
Targets L-type calcium燾hannel [1]
IC50 0.15 nM
In vitro Felodipine significantly relaxes KCl-contracted porcine coronary segments by blocking the Ca2+ channels, displaying ~50 times more potent than nifedipine (IC50 of ~8 nM) and ~430 times than verapamil (IC50 of ~65 nM). [1] Felodipine significantly induces the transcription and secretion of IL-6 and IL-8 with ED50 values of 5.8 nM and 5.3 nM in primary human VSMC and lung fibroblasts, respectively, while propranolol or furosemide fails to affect the expression of the two IL genes. [2] Felodipine blocks the muscarinic receptor-mediated (carbachol) Ca2+-dependent contraction of guinea pig ileum longitudinal smooth muscle (GPILSM) with an IC50 of 1.45 nM. [3] Felodipine at low concentration of 0.1 μM is sufficient to increases NOx generation, Ca2+-dependent NOS activity, and eNOS protein mass in rat endothelial cells. [4] Felodipine (10 μM) reduces nuclear translocation of p42/44 mitogen-activated protein kinase and Elk-1 activation stimulated by PDGF-BB, leading to the inhibition of human SMC proliferation. [5] Felodipine modestly blocks the Cav3.2 T-type Ca2+-channel with an IC50 of 6.8 μM. [6]
In vivo Oral administration of Felodipine significantly reduces the average blood pressure (BP) in rats with 5/6 renal ablation, but causes additional impairment of the already impaired renal autoregulation. [7] Administration of Felodipine significantly reduces systolic blood pressure (SBP), serum insulin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) by blocking NF-κB activation, and decreases macrophages in the aortic wall, leading to the modulation of vascular inflammatory response. [8]
Features Unlike many Ca2+ channel blockers, Felodipine does not have cardiac side effects due to high selectivity for vascular smooth muscle vs. myocardial tissue.

Protocol(Only for Reference)

Kinase Assay: [1]

The effect of Felodipine on tension in coronary segments The cylindrical coronary segments from porcine hearts are inverted and fixed horizontally between a stationary bottom pin and a top pin connected to the lever of a force-displacement transducer precalibrated with standard weights on a Grass model 5D polygraph. The cylindrical segments are bathed in 25 mL of PSS in a water jacketed tissue bath at 37 °C. The bath solution is bubbled continuously with a mixture of 95% O2-5% CO2. An initial resting tension of 10 g is set during a 2-hour equilibration period. After the equilibration, three to four successive contraction-relaxation cycles are induced with 35 mM KCl and subsequent washes with PSS until reproducible contractions are obtained. After the final response reached and maintained steady tension (16-25 g above resting tension), a cumulative dose-response curve for Felodipine is obtained. Additional aliquots of Felodipine are added only after the response to the previous dose has plateaued. The concentration of Felodipine that half-maximally relaxes the coronary from KCl-induced contraction (IC50) is determined from dose response curv

Animal Study: [7]

Animal Models Male Sprague-Dawley rats with approximately 5/6 renal ablation
Formulation Dissolved in DMSO, and diluted in saline
Dosages 1 g/kg/day
Administration Orally
1

References

[1] Johnson JD, et al. J Pharmacol Exp Ther, 1983, 226(2), 330-334.

[2] R?dler S, et al. J Mol Cell Cardiol, 1995, 27(10), 2295-2302.

view more

Clinical Trial Information( data from http://clinicaltrials.gov)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT00742066 Active, not recruiting Hypertension|Insulin Resistance|Microcirculation Maastricht University Medical Center 2008-03
NCT01238705 Recruiting Hypertension|Sexual Dysfunction LanZhou University 2008-04 Phase 4
NCT00905333 Completed Healthy AstraZeneca; Scentryphar Clinical Research; Cori Analyticals; Clínica São Lucas, Hospital Sírio Libanês de Itatiba S/C; LabClin Laboratório Clínico; Laboratório de Patologia Clínica Dr. Franceschi Ltda.; Faculdade de Ciências Farmacêuticas de Ribeirão Preto - Centro de Bioequivalência 2008-10 Phase 1
NCT00841880 Completed Hypertension Sanofi 2009-01 Phase 4
NCT01520285 Recruiting Hypertension Lee's Pharmaceutical Limited 2012-02 Phase 4

Chemical Information

Download Felodipine SDF
Molecular Weight (MW) 384.25
Formula

C18H19Cl2NO4

CAS No. 72509-76-3
Storage 3 years -20℃Powder
6 months-80℃in DMSO
Synonyms
Solubility (25°C) * In vitro DMSO 77 mg/mL (200 mM)
Water <1 mg/mL (<1 mM)
Ethanol 72 mg/mL (187 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Research Area

Tech Support & FAQs

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Calcium Channel Products

  • Selinexor (KPT-330)

    Selinexor (KPT-330) is an orally bioavailable selective CRM1 inhibitor. Phase 2.

  • KPT-185

    KPT-185 is a selective CRM1 inhibitor.

  • CFTRinh-172

    CFTRinh-172 is a voltage-independent, selective CFTR inhibitor with Ki of 300 nM, showing no effects on MDR1, ATP-sensitive K+ channels, or a series of other transporters.

  • Cilnidipine

    Cilnidipine is a calcium channel blocker.

  • Ranolazine 2HCl

    Ranolazine 2HCl, is an antianginal medication.

  • Amlodipine

    Amlodipine is a long-acting calcium channel blocker with an IC50 of 1.9 nM.

  • Isradipine

    Isradipine is a calcium channel blocker with an IC50 of 34±8 μM.

  • Manidipine 2HCl

    Manidipine 2HCl is a HCl salt form of Manidipine, which is a calcium channel blocker with IC50 of 2.6 nM, used clinically as an antihypertensive. Phase 4.

  • Nimodipine

    Nimodipine is a dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity.Nimodipine decreases intracellular free Ca2+,Beclin-1 and autophagy.

  • Lacidipine

    Lacidipine is a L-type calcium channel blocker.

Recently Viewed Items

Tags: buy Felodipine | Felodipine ic50 | Felodipine price | Felodipine cost | Felodipine solubility dmso | Felodipine purchase | Felodipine manufacturer | Felodipine research buy | Felodipine order | Felodipine mouse | Felodipine chemical structure | Felodipine mw | Felodipine molecular weight | Felodipine datasheet | Felodipine supplier | Felodipine in vitro | Felodipine cell line | Felodipine concentration | Felodipine nmr
Contact Us